Diagnostic accuracy of quantitative fetal fibronectin to predict spontaneous preterm birth: A meta-analysis. 2021

Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
Department of Gynecology and Obstetrics, Shantou Jinping Women and Children's Hospital, Shantou, Guangdong, China.

BACKGROUND Use of quantitative fetal fibronectin (fFN) testing to predict spontaneous preterm birth (sPTB) is gaining attention owing to its absolute measurement of fFN concentration and increased positive predictive value compared with qualitative testing. OBJECTIVE To assess the predictive values of quantitative fFN for sPTB in different predefined thresholds using systematic review and meta-analysis. METHODS Five major databases (PubMed, ScienceDirect, Web of Science, Embase, Cochrane library) were searched for eligible studies. METHODS Observational studies of the diagnostic accuracy of different quantitative fFN thresholds on delivery outcomes were included. METHODS Articles were reviewed independently by two authors and data were extracted. Sensitivity, specificity, diagnostic odds ratio, and summary receiver operating characteristic curves were extracted and calculated. RESULTS Fifteen studies were included. To detect sPTB at less than 34 weeks of gestation, pooled sensitivities for thresholds of 10, 50, 200, and 500 ng/ml were 0.78, 0.56, 0.33, and 0.11, respectively. Pooled specificities were 0.63, 0.84, 0.96, and 0.99, respectively. CONCLUSIONS Based on the results of the meta-analysis, the threshold of 10 ng/ml fFN may be a new choice for the prediction of sPTB. The improved diagnostic accuracy of quantitative testing over qualitative testing can provide additional discriminatory information for clinical practice.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D047928 Premature Birth CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION). Preterm Birth,Birth, Premature,Birth, Preterm,Births, Premature,Births, Preterm,Premature Births,Preterm Births

Related Publications

Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
January 2016, Women's health (London, England),
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
July 2017, JAMA,
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
July 2017, JAMA,
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
February 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
May 2015, Obstetrics and gynecology,
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
December 2023, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
May 2007, Obstetrics and gynecology,
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
February 2013, American journal of obstetrics and gynecology,
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
January 2015, American journal of obstetrics and gynecology,
Jingning Chen, and Guoliang Gong, and Wenhua Zheng, and Jingyun Xu, and Xiaowei Luo, and Yuanxin Zhang
September 2021, Health technology assessment (Winchester, England),
Copied contents to your clipboard!